APA (7th ed.) Citation

Wang, Y., Liu, Y., Wu, H., Xu, S., & Ma, F. (2022). Identification of a Hydrogen-Sulfide-Releasing Isochroman-4-One Hybrid as a Cardioprotective Candidate for the Treatment of Cardiac Hypertrophy. MDPI AG.

Chicago Style (17th ed.) Citation

Wang, Yu, Yuechen Liu, Hongyu Wu, Shengtao Xu, and Fenfen Ma. Identification of a Hydrogen-Sulfide-Releasing Isochroman-4-One Hybrid as a Cardioprotective Candidate for the Treatment of Cardiac Hypertrophy. MDPI AG, 2022.

MLA (9th ed.) Citation

Wang, Yu, et al. Identification of a Hydrogen-Sulfide-Releasing Isochroman-4-One Hybrid as a Cardioprotective Candidate for the Treatment of Cardiac Hypertrophy. MDPI AG, 2022.